This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More

Bioprocess Technology Market

Bioprocess Technology Market by Product (Upstream Equipment, Lab-scale Bioreactors, Scale-up and production products, Testing Products), End-User (Biotech/Biopharmaceutical Companies, CDMO/Contract Research Organization, Research/Academic Institutes) & Region - Forecast to 2021-2031

Bioprocess Technology Market by Product (Upstream Equipment, Lab-scale Bioreactors, Scale-up and production products, Testing Products), End-User (Biotech/Biopharmaceutical Companies, CDMO/Contract Research Organization, Research/Academic Institutes) & Region - Forecast to 2021-2031

Bioprocess Technology Market - Analysis, Outlook, Growth, Trends, Forecasts

Bioprocess Technology Market Snapshot

[245 Pages Report]  The global Bioprocess Technology Market was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period from 2021 to 2031. It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031.

With consumer awareness regarding Bioprocess Technology on the rise, companies are focusing on the launch of next-generation bioprocess products and engaging synergistic approaches for distribution and manufacturing through various market consolidation activities.

Key Points Covered in Bioprocess Technology Market Study

  • Market estimates and forecast 2016-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Bioprocess Technology Market and How to Navigate
  • Recommendation on Key Winning Strategies

2016-2020 Bioprocess Technology Products Demand Outlook Compared to 2021-2031 Forecast

According to Future Market Insights (FMI), the Bioprocess Technology market was valued at US$ 17.3 Bn in 2020. The increasing focus on alternative medicines and preventive measures is driving current sales figures. Expansion and product launches in emerging markets are key factors promoting the market growth.

The leading companies are focusing on the expansion of their manufacturing capabilities with high flexibility and rapid operations. They also are emphasizing on the development and launch of next-generation bioprocess products. The current bioprocess product-development pipeline supports an outlook of continued healthy growth.

The market is consolidated and is dominated by players such as Thermo Fisher Scientific Inc., Sartorius, Merck KGaA, Danaher Corporation and Lonza Group AG among others. Future Market Insights expects the global market to grow at a CAGR of 15.2% over the forecast period by 2031-end.

How is the Adoption of Bioprocess Technology Aiding Market Growth?

The primary factor for the preference of the single-use (disposable) bioreactor in the bioprocess industry is the production of different biopharmaceutical therapeutics, using the same facility, in minimum time and with minimum cost.

The rising demand for personalized treatment for diseases like cancer is expected to increase the demand for bioprocess therapies like cell therapy. The decreasing cost of genetic sequencing shortly has enabled the development of personalized treatment plans and targeted therapies, which are more effective than less-specific therapies because they focus on a patient’s genetic and molecular makeup.

Techniques for process intensification also are being applied to biosimilar manufacturing. The increasing use of biosimilars in developed countries of Europe and the United States will boost the speed of the bioprocess technology adoption for rapid production of biosimilars.

What are the Key Opportunities for Market Players?

Favorable government policies for start-up companies, especially in developing countries are expected to create opportunities for the market players to invest in the bioprocess technology market.

Mergers, acquisitions & expansion of manufacturing facilities around the globe are expected to bose well for the market in the coming years. Introducing advanced bioprocess products to leverage untapped market opportunities will remain a key growth driver.

What is the Impact of the COVID-19 Crisis on the Market?

The COVID-19 pandemic is expected to positively impact growth. It has created ample opportunities for players due to the increasing demand for bioprocess technology. Consumer behavior connected to epidemiological stages and government responses to the pandemic are resulting in high demand for bioprocess technology.

The outbreak has changed distribution channel operations and pushed traffic to e-commerce options. Supply chains were hampered during the second quarter of 2020 due to trade blocks that occurred globally to stop the surging cases of virus. These factors are however likely to subside through 2021 and beyond.

Vaccines are biopharmaceutical products, therefore, their manufacturing will require bioprocess technology.

Country-wise Insights

Will the U.S. Remain the Leader in Bioprocess Technology Market?

In 2021, the U.S. is estimated to account for over 89.6% value share in North America. The dominance is driven by increasing requirements of upstream equipment. Rising living standards, health consciousness, and increasing disposable incomes are boosting the demand for effective treatments with minimal side effects.

What are the Factors Supporting Bioprocess Technology Demand in the UK?

The UK market will exhibit a 12.4% CAGR throughout the forecast period. The use of single-use technologies, personalized treatment of rare diseases, and increase use of biosimilar had led to the rise in the demand for bioprocess technology.

What will Support Bioprocess Technology Market Growth in India?

The India bioprocess technology market is likely to grow at a CAGR of 18.6% during the forecast period. It is expected to account for a market share of 52.4% in the South Asia. Major factors that are supporting growth of the India bioprocess technology market are the production of biopharmaceuticals like recombinant proteins and vaccines.

India also is known as a leading hub for vaccine manufacturing, which inevitably makes it a key market for bioprocess technology.

What are the Factors Fuelling Demand for Bioprocess Technology in Germany?

The Germany bioprocess technology market is likely to grow at a CAGR of 10.9% during the forecast period. It is expected to account for a share of 27.4% in the Europe market. The rise in the demand for biopharmaceuticals, the need to reduce wastage, and prevent contamination are the major factors that will drive the demand of the bioprocess technology market in Germany.

What is the Outlook for Bioprocess Technology Market in China?

The China bioprocess market technology is likely to grow at a CAGR of 10.3% during the forecast period. It is expected to hold a share of 45.9% in the East Asia bioprocess technology market.

Category-wise Insights

Which is the Preferred Product in Bioprocess Technology Market?

With the advent of new technologies in recent years, the bioprocess technology market is growing and has become one of the most significant sectors in the healthcare industry. By product, upstream was the dominant segment in 2020, occupying a market share of 65.2% revenue.

Who is the Leading End User of Bioprocess Technology?

Based on end user, biotech/biopharmaceutical companies will continue dominating the global bioprocess technology market. The segment is expected to hold a market share of 44.0% in 2021.

Competitive Landscape

The bioprocess technology market players are primarily aiming at strategic expansions to consolidate growth in a competitive market.

For instance, in Oct 2018, Thermo Fisher Scientific announced a $50 million (€44 million) expansion at a CDMO plant in St Louis, Missouri, U. S. to add 16,000 L of single-use capacity due to extremely strong growth in demand for commercial biologics manufacturing. As per the company, the facility will be the largest outsourced single-use biologics site in North America.

In June 2020, Lonza has developed the new innovative platform technology, New GSv9 TM media and feeds maximize yield and batch-to-batch consistency to support recombinant protein production scale-up. This provides a robust culturing platform that can reproducibly generate high-quality, stable proteins.

In March 2020 Danaher acquired the Biopharma business of General Electric Life Sciences, which is a leading provider of instruments, consumables, and software.

The greater the demand for bioprocesses products, the stronger is the pipeline, which will lead to increase demand in the market. Leading industry players are focusing on the launch of next-generation bio therapeutics to treat serious life-threatening diseases.

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD Million for Value.

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Product, End users,  and Region

Key Companies Profiled

  • Thermo Fisher Scientific Inc
  • Sartorius, Merck KGa 
  • Danaher Corporation (Pall Biotech and Cytiva) 
  • Merck KGaA
  • STADA Arzneimittel AG
  • Danaher Corporation
  • Applikon Biotechnology B.V. (Getinge)
  • Lonza AG
  • Bio-Rad Laboratories
  • Agilent technologies
  • Solida Biotech GmBH
  • Waters Corporation

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Sign Up with MarketNgage

World's Most Profilic Intelligence Engine

Get Access To The World's Largest Market Research Database.

Sign Up Now

Bioprocess Technology Market by Category

Product:

  • Upstream Equipment
    • Cell culture development products
      • Cell line development products
      • Cell Lines
      • Media, Sera and other additives
      • Cell line development kits
  • Lab-scale Bioreactors
    • Continuous Stirred Tank Bioreactors
    • Bubble Column Bioreactors
    • Airlift Bioreactors
    • Fluidized Bed Bioreactors
    • Packed Bed Bioreactors
    • Photo-Bioreactors
  • Scale-up and production products
    • Cell culture media and feeds
    • BioProcess Containers & Fluid Transfer Solutions
      1. Single-use
      2. Reusable
    • BioReactors
      1. Single-Use Bioprocess Equipment
      2. Continuous Bioprocess Equipment
      3. Real-Time Bioprocess Equipment
    • Harvest and collection
      • Harvest and separation products
      • Centrifuges for bioprocessing
      • Storage & Transport Products
        v. Production Tanks and Drums
        v. Outer Support Containers
  • Testing Products
    • Cell Counters & Viability Analysis Systems
    • Contamination & impurity testing products
  • Probes and Accessories
  • Downstream Equipment
    • Downstream purification
      • Chromatography Instruments
      • Chromatography Columns
      • Others (Resins and accessories)
    • Buffer preparation and supply
      • Reagents
      • mixing systems
  • Process analytical testing
    • Host cell residual DNA quantitation
    • Protein quantitation
    • Microbial identification
    • Others
  • Probes and Accessories

End-User:

  • Biotech/Biopharmaceutical Companies
  • CDMO/Contract Research Organization
  • Research/Academic Institutes

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Key Questions Answered in the Report

How much is the bioprocess technology market worth?

The global bioprocess technology market was valued at US$ 17,296.4 Mn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81,215.7 Mn by the end of 2031.
The global bioprocess technology market is projected to register high demand in the forecast period and rise at a CAGR of 15.2%.
The key drivers of the bioprocess technology market are increasing spending on life science research, strong biologics pipeline, and capital investments to aid advancements biotechnology.
Rising adoption of single-use (disposable) bioprocessing technology, growth in personalized treatment for rare diseases, and increase in the use of biosimilar are the major factors driving demand in the bioprocess technology market.
The cumulative market share of the top players including Thermo Fisher Scientific Inc, Merck KgaA and Danaher Corporation holds around 65% of the overall market.
India, China, the U.S., Japan, and Germany are the top 5 countries that are driving the demand for bioprocess technology.
North America will hold around 33.6% revenue share in the overall bioprocess technology market in 2021. The US remains the fastest growing market in North America, with the demand for bioprocess technology forecast to rise at a CAGR of 10.5% over the forecast period.
The Europe market is set to exhibit a CAGR of 14.1% during the forecast period owing to the high demand for cell development products and lab-scale bioreactors in the upstream segment.
Thermo Fisher Scientific Inc, Sartorius, Merck KGa, Danaher Corporation (Pall Biotech and Cytiva), Merck KGaA, Danaher Corporation, Applikon Biotechnology B.V. (Getinge), Lonza AG, Bio-Rad Laboratories, Agilent technologies, Solida Biotech GmBH, Waters Corporation are key players in this market.

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

Central Venous Catheter Market

Published : 2016-11-08

Healthcare

Surface Plasmon Resonance Spr Systems Market

Published : 2020-02-04

Healthcare

Breast Pumps Market

Published : 2016-05-10

Healthcare

Us Compounding Pharmacies Market

Published : 2022-01-13